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Albumin induces oxidative stress and cytokine production in
proximal tubular cells (PTECs). Albumin-bound fatty acids
(FAs) enhance tubulopathic effects of albumin in vivo. We
proposed that FA aggravation of albumin-induced oxidative
stress in PTECs might be involved. We hypothesized that
mitochondria could be a source of such stress. Using a
fluorescent probe, we compared reactive oxygen species
(ROS) production after exposure of PTECs to bovine serum
albumin (BSA) alone or loaded with oleic acid (OA-BSA)
(3–30 g/l for 2 h). There was no difference in cellular albumin
uptake, but OA-BSA dose-dependently induced more ROS
than BSA alone (Po0.001). OA-BSA-induced ROS was
significantly alleviated by mitochondrial inhibition, but not by
inhibitors of nicotinamide adenine dinucleotide phosphate
hydrogenase (NADPH) oxidase, xanthine oxidase, or nitric
oxide synthase. Gene expression analysis showed that neither
the NADPH oxidase component p22phox nor xanthine
oxidase was induced by BSA or OA-BSA. OA-BSA, in contrast to
BSA, failed to induce mitochondrial manganese superoxide
dismutase 2 (SOD2) expression. OA-BSA showed a greater
capacity than BSA to downregulate heme oxygenase-1 mRNA
expression and accentuate inflammatory cytokine mRNA and
protein. Supplementation of SOD activity with EUK-8 reduced
ROS, and interleukin-6 protein expression was suppressed by
both mitochondrial inhibition and SOD augmentation. Thus, in
PTECs, FAs accentuate albumin-induced oxidative stress and
inflammatory cytokine expression via increased mitochondrial
ROS, while frustrating protective antioxidant responses.
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Proximal tubular epithelial cells (PTECs) treated with excess
albumin produce numerous pro-oxidant and proinflamma-
tory substances.1–6 There is evidence that such albumin-
stimulated PTEC activity contributes to tubulointerstitial
inflammation in vivo. For example, in human nephrotic
kidneys, interleukin 8 (IL-8) mRNA and protein localized
mainly to tubular epithelial cells, and the distribution of
infiltrating interstitial leukocytes approximated with IL-8-
expressing tubules.7 Similarly, in proteinuric rats, osteopon-
tin was upregulated in proximal tubules with adjacent
interstitial inflammatory infiltrates.8 These findings indicate
that PTECs are not merely structural elements but are active
players in pathophysiologic processes. Oxidative stress plays a
key role in these events. In PTECs exposed to albumin,
increased intracellular production of reactive oxygen species
(ROS) was required for activation of nuclear factor kappaB
and expression of IL-87 and macrophage chemoattractant
protein 1.9
Some effects of albumin on PTECs are not owing to the
molecule itself, but rather to fatty acids (FAs) bound to it.
Excess PTEC fibronectin production was induced by oleic
acid-complexed albumin but not by pure albumin.10 FA
presented to PTECs via albumin is efficiently taken up,
leading to such effects as altered cellular growth,11 disturbed
metabolism,11,12 increased apoptosis,13 and the release of
lipid metabolites with immunologic14 and biochemical15
properties that may be pathologically important. The concept
of albumin-bound FA toxicity is supported by in vivo
evidence. In rodents, we16 and others17,18 have found that
albumin-bound FAs aggravate albumin-induced nephro-
pathic effects, including renal cortical apoptosis,17 tubuloin-
terstitial inflammation,16–18 and glomerular injury.16
Moreover, nephrotic patients with the relatively benign
minimal change disease (MCD) have more than threefold
lower urinary albumin FA content than individuals with non-
MCD varieties of nephrosis that tend to run a more
aggressive course.19 These observations together indicate that
albumin-bound FA exerts extra deleterious effects on PTECs,
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on top of those of albumin alone. However, information
about these processes remains limited, and in particular it is
not known whether albumin-bound FA can increase
oxidative stress.
We employed an in vitro protein overload model of
cultured PTECs to explore two questions relating to the idea
that albumin-bound FAs exaggerate oxidant effects of
albumin on PTECs. First, we postulated that FAs increase
the ROS-inducing capacity of albumin. We tested this
hypothesis by comparing ROS production after exposure to
bovine serum albumin (BSA) either alone or loaded with
oleic acid (OA-BSA). We found that cells exposed to OA-BSA
produced up to 2.5-fold more ROS than those treated with
BSA alone. Second, we explored the source of OA-BSA-
induced ROS in these cells. Evidence from another cell type
suggests that FAs stimulate ROS production from the
mitochondria.20 In vascular endothelial cells exposed to
lipids, there is an important mitochondrial contribution to
ROS.21 Thus, we hypothesized that mitochondria may also be
a major source in PTECs upon treatment with albumin-
bound FAs. Our findings supported this hypothesis. We went
further to assess the responses of cellular antioxidant defence
mechanisms to the FA-induced disturbance of redox balance,
and to explore whether the resultant excess oxidant stress is
of functional consequence in terms of cellular proinflamma-
tory transcriptional and translational activity. The present
study reveals a failure in the mitochondrial antioxidant
response as a mechanism by which FAs bound to albumin
can induce oxidative and inflammatory stresses in PTECs.
RESULTS
FA binding has no effect on albumin uptake by HK-2 cells
Electro-immunodiffusion assays (Table 1) showed similar
albumin uptake by HK-2 cells after BSA or OA-BSA
treatment for 2 h, in a dose-dependent manner. Similar
uptake was also visualized by immunohistochemistry (not
shown). The results are comparable with previous findings in
similar cells.22–24
OA-BSA induces more ROS than BSA
Incubation of HK-2 cells with OA-BSA for 2 h resulted in
markedly and significantly greater ROS production than BSA
alone, at every concentration tested. OA-BSA induced ROS
dose-dependently (up to fourfold increase from control
level), whereas BSA induced moderate (up to 1.5-fold) ROS
increase, which attained significance only at the highest
concentration (Figure 1a). Cell viability was not impaired by
2-h BSA or OA-BSA exposure (3-[4,5-dimethylthiazol]-2,5-
diphenyltetrazolium bromide (MTT) and lactate dehydro-
genase (LDH) release assays; Figure 1b).
The property of albumin as an excellent carrier for many
hydrophobic substances (besides FAs) raises the concern that
it could acquire unknown contaminants in the course of
commercial preparation and purification processes. To
confirm that the effects we observed were not influenced by
such contamination, we repeated some experiments using a
different formulation of low endotoxin (0–2.0 EU/mg), low
FA (0–0.2 mg/g) BSA (SERVA Electrophoresis GmbH,
Heidelberg, Germany). As shown in Table 2, the pattern of
ROS production induced by the SERVA product was similar
to that of the Sigma product described in the above
paragraph.
Table 1 | Albumin uptake after exposure to albumin with or
without bound OA
Treatment: albumin
concentration (g/l)
Cellular albumin content
after 2 h (lg BSA/mg total
cellular protein)
Control 0 0
BSA 3 12.3 (2.7)*
15 32.4 (2.3)*,#
30 45.2 (2.4)*,#
OA-BSA 3 13.6 (1.8)*
15 24.8 (2.5)*,#
30 42.0 (6.9)*,#
BSA, bovine serum albumin; OA, oleic acid.
Mean (s.e.m.) of three independent experiments (mg albumin/mg total cellular
protein).
*Po0.001 vs control,
#Po0.05, ##Po0.01 vs 3 g/l.
There were no significant treatment or time differences.
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Figure 1 | Effects of BSA and OA-BSA on cellular ROS production
and viability. (a) ROS production after exposure to albumin (BSA)
alone or enriched with oleic acid (OA-BSA) in proximal tubular
epithelial cells (PTECs), measured by DCF fluorescence normalized to
control values (a.u.). *Po0.05, **Po0.001 vs control (untreated) cells;
#Po0.001, OA-BSA vs corresponding BSA concentration. Mean
(s.e.m.) of at least three independent experiments is shown. (b) MTT
and LDH release assays. Cells exposed to cumene hydroperoxide for
the same duration were used as positive control. *Po0.05,
**Po0.001 vs all other groups. Mean (s.e.m.) of three independent
experiments is shown.
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OA-BSA-induced ROS is alleviated by mitochondrial
inhibitors
In further experiments, cells were exposed to OA-BSA (30 g/l)
for 2 h. In intervention studies to probe possible sources of
ROS (Figure 2), OA-BSA-induced increase was significantly
attenuated by the mitochondrial respiratory chain blockers
rotenone (ROT) (complex I inhibitor) and carbonyl cyanide 3-
chlorophenylhydrazone (CCCP) (respiratory uncoupling
agent), but not by 2-thenoyltrifuoroacetone (complex II
inhibitor). The specific nicotinamide adenine dinucleotide
phosphate hydrogenase (NADPH) oxidase inhibitor apocynin
(APO) had no significant effect. No-nitro-L-arginine methyl
ester and allopurinol also had no effect, excluding uncoupled
nitric oxide synthase or xanthine oxidase as ROS sources.
p22phox and xanthine oxidase genes are not induced
by OA-BSA
To probe whether BSA or OA-BSA induce pro-oxidant
transcriptional changes that could influence cellular ROS
sources, we performed reverse transcription-polymerase
chain reaction (PCR) studies on the NADPH components
p22phox (cytosolic component) and rac1 and rac2 (mem-
brane-bound components). We also tested the xanthine
oxidase gene. Although rac1 and rac2 were both induced by
either treatment, the vital enzyme component p22phox was
not. There was no change in xanthine oxidase expression.
Illustrative PCR bands and semiquantitative densitometry of
gene expression are shown (Figure 3a).
Mitochondrial antioxidant SOD2 gene induction, seen with
BSA, fails with OA-BSA
We assessed the transcriptional response of major cellular
antioxidant enzymes (Figure 3b). In cells treated with BSA
alone, there was notable upregulation of manganese super-
oxide dismutase (SOD2) despite the comparatively mild ROS
increase. In marked contrast to BSA, OA-BSA failed to induce
SOD2. Expression of other redox enzyme genes, copper–zinc
superoxide dismutase (SOD1) and glutathione peroxidase,
was not significantly regulated by either treatment.
ROS increase is ameliorated by EUK-8, a synthetic SOD
analog
To explore the functional implication of the antioxidant
gene expression pattern noted above, we tested whether
supplementation of SOD might alleviate ROS induced by
OA-BSA. We used the saleno-manganese SOD mimetic agent
EUK-8, which indeed markedly alleviated ROS (Figure 4).
Downregulation of heme oxygenase-1 is enhanced by
OA-BSA
For an insight into whether bound FAs might also influence
albumin-induced inflammatory effects, we studied the gene
expression of cytokines IL-6 and IL-8. Both treatments
similarly increased cytokine expression. However, OA-BSA
had a greater tendency to suppress the expression of heme
oxygenase-1 (HO-1) (Figure 3c), a molecule with important
renal antioxidant and anti-inflammatory effects.25,26
OA-BSA aggravates oxidant-sensitive IL-6 protein expression
To assess whether the observed effects in gene expression are
reflected at protein level, we measured IL-6 in cells treated
with BSA or OA-BSA. OA-BSA induced significantly greater
cellular expression of IL-6 protein than BSA (Table 3), despite
their similar effect at the level of gene expression. We then
Table 2 | ROS measurement after treatment of HK-2 cells with
a different albumin formulation
Albumin content (g/l) BSA OA-BSA
3 1.5 (0.2) 2.4 (0.2)**,##
15 1.9 (0.2)** 3.3 (0.4)**,#
30 2.3 (0.4)* 3.6 (0.5)**,##
0 (control) 1.0 (0.03)
BSA, bovine serum albumin; HK-2, human kidney-2; OA, oleic acid; ROS, reactive
oxygen species.
Mean (s.e.m.) of three independent experiments.
*Po0.01, **Po0.001 vs control.
#Po0.05, ##Po0.01, BSA vs OA-BSA.
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Figure 2 | Effects of inhibitors of ROS sources on stimulated and
basal cellular ROS production. (a) ROS production by HK-2 cells
after OA-BSA treatment in the presence or absence of blockers of
potential ROS sources. Mitochondrial inhibitors used were CCCP
(uncoupling agent), rotenone (ROT) (complex I), and 2-thenoyltri-
fuoroacetone (complex II). No-nitro-L-arginine methyl ester is a nitric
oxide synthase inhibitor, APO an NADPH oxidase inhibitor, and
allopurinol (ALLO) a xanthine oxidase inhibitor. *Po0.001 vs OA-BSA.
Mean (s.e.m.) of at least three independent experiments is shown.
(b) Effects of the above-named intervention agents on baseline
(control) cellular ROS levels.
726 Kidney International (2006) 70, 724–731
o r i g i n a l a r t i c l e DA Ishola et al.: Albumin-bound fatty acid and tubular cell oxidant stress
tested whether antioxidant intervention would ameliorate the
effect of OA-BSA. The saleno-manganese complex and SOD
mimetic agent EUK-8, and the mitochondrial blockers
rotenone and CCCP, all reduced IL-6 protein expression to
baseline (control) levels. The intervention agents acting alone
did not significantly alter baseline levels (not shown).
DISCUSSION
The present study provides observations suggesting that
albumin-bound FAs augment the oxidative capacity of
albumin on PTECs via excess mitochondrial ROS, in the
face of an impaired mitochondrial ROS-scavenging response.
A complex of albumin with OA (OA-BSA) significantly and
dose-dependently increased intracellular ROS much more
than albumin alone (BSA). OA-BSA stimulation experiments
in the presence of various inhibitors implicated mitochondria
and not NADPH oxidase, xanthine oxidase, or nitric oxide
synthase as the main source of ROS. A manganese SOD
mimetic agent, EUK-8, alleviated the OA-BSA-induced ROS
increase. Not only did OA-BSA markedly increase mitochon-
drial ROS, but also adversely affected gene expression of the
key mitochondrial antioxidant system, the manganese-
containing SOD2. Whereas BSA induced protective SOD2
gene expression, this response was completely absent with
OA-BSA. Parallel to increased oxidative stress, OA-BSA
aggravated the protein expression of the inflammatory
cytokine IL-6 beyond the level of BSA alone. This effect
was redressed by both SOD supplementation and mitochon-
drial inhibition, suggesting that the dual-mechanism oxidant
effect of albumin-bound FAs promotes proinflammatory
PTEC activity.
There is as yet no broad consensus regarding the specific
sites of ROS production on the mitochondrial electron
transport chain. Complex I is thought to be important, but
complexes II and III are also known to be capable of ROS
production, and there are variations between tissues.27,28 We
probed possible ROS contribution from complexes I and II,
and from the respiratory coupling step. Only the complex II
inhibitor 2-thenoyltrifuoroacetone failed to substantially
reduce OA-BSA-induced ROS, suggesting complex I as the
key location of ROS production within PTEC mitochondria.
In experiments probing other possible ROS sources apart
from mitochondria, APO, a specific inhibitor of NADPH
oxidase complex assembly,29 failed to attenuate ROS. More-
over, gene expression studies indicated that the crucial
NADPH oxidase component p22phox was not induced by
OA-BSA. p22phox plays an essential role in NADPH oxidase
function by facilitating transfer of the cytosolic elements to
the membrane, enabling catalytic activation.30 Interestingly,
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Figure 3 | Illustrative bands from reverse transcription-polymer-
ase chain reaction experiments, normalized to 18S and related to
control levels, showing transcriptional changes induced by BSA
and OA-BSA. C, control; B, BSA; O, OA-BSA. Densitometric data are
shown as median (range) fold difference vs control, 4–5 independent
experiments, *Po0.05, BSA vs OA-BSA (Friedman). (a) Expression
pattern of pro-oxidant genes: NADPH oxidase components (rac1,
rac2, p22phox) and xanthine oxidase. (b) Expression of antioxidant
genes: SOD1, SOD2, glutathione peroxidase. (c) Expression of genes
of downstream mediators: inflammatory cytokines IL-6 and IL-8, and
the antioxidant molecule HO-1.
EUK-8 ameliorates OA-BSA-induced ROS
Con OA-BSA OA-BSA+EUK EUK
R
e
la
ti
v
e
 D
C
F
 f
lu
o
re
s
c
e
n
c
e
0
1
2
3
4
5
*
Figure 4 | ROS production by HK-2 cells after OA-BSA treatment
in the presence or absence of EUK-8, a manganese SOD mimetic.
*Po0.001 vs all other groups.
Table 3 | IL-6 protein expression in HK-2 cells after treatment
with BSA or OA-BSA
IL-6 (ng/mg total cellular protein)
Control 0.96 (0.1)
BSA 1.65 (0.2)*
OA-BSA 2.38 (0.4)**
OA-BSA+EUK-8 1.16 (0.2)
OA-BSA+rotenone 0.90 (0.4)
OA-BSA+CCCP 1.10 (0.4)
CCCP, carbonyl cyanide 3-chlorophenylhydrazone; BSA, bovine serum albumin; IL,
interleukin; OA, oleic acid.
Mean (s.e.m.) of up to eight independent experiments.
*Po0.05 vs control.
**P=0.005 vs control.
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we found that PTECs robustly express both of the low
molecular weight G-protein NADPH oxidase complex
components rac1 and rac2. Both molecules tended to be
upregulated after OA-BSA treatment, but apparently without
functional significance in the absence of p22phox induction.
In further inhibition studies of cellular ROS-producing
enzymes, neither nitric oxide synthase inhibition with No-
nitro-L-arginine methyl ester nor blockade of xanthine
oxidase with allopurinol yielded significant reductions in
ROS.
Marked reduction of OA-BSA-induced ROS was observed
with EUK-8, a manganese–salen compound that possesses
efficient catalytic SOD antioxidant activity.31,32 Crucially,
EUK-8 also has potent catalase activity, precluding the risk of
SOD-driven H2O2 accumulation. Thus, an SOD/catalase
enzymatic axis (driving the reaction sequence O2
K-
H2O2-H2OþO2) appears to be the pivotal redox pathway
in this OA-BSA model of PTEC protein overload (Figure 5).
Gene expression of other cellular antioxidant enzymes, SOD1
and glutathione peroxidase, was not regulated by either BSA
or OA-BSA.
Mitochondria produce ROS during the course of normal
cellular metabolism, and the local scavenging action of
mitochondrial SOD (SOD2) is a major protector of the
organelle, and indeed the whole cell, from auto-oxidation
(via ROS diffusion into the cytoplasm).33 Excess mitochon-
drial ROS can have devastating effects, as illustrated by severe
lifespan reductions in SOD2 null mice.27,33 This contrasts
with remarkably milder phenotypes in mice lacking other
SOD isoforms. In the present study, OA-BSA increased
mitochondrial ROS and suppressed the protective gene
induction of SOD2 seen with BSA alone.
To further assess the cellular defensive response to
increased oxidative stress, we examined the gene expression
of HO-1, a widely distributed enzyme that plays an
important role in maintaining cellular redox balance. HO-1
induction is seen as a defensive response to injurious
stimuli25 and is specifically protective of PTECs against
various types of oxidant agents.26 Contrary to our expecta-
tion of increased expression as an attempt to counter oxidant
stress, we surprisingly observed that HO-1 was down-
regulated in PTECs exposed to BSA, an effect that was
enhanced by OA-BSA. Thus it appears that, apart from
aggravating albumin-induced oxidative stress, albumin-borne
FAs also further depress the HO-1 antioxidant protection.
However, in contrast to our finding of suppressed HO-1
expression in protein-overloaded human PTECs, it was
recently reported that no changes occurred in HO-1
expression in kidneys of rats that received a brief course of
albumin injections (7 days), or in cultured rat PTECs that
were exposed to albumin.34 This contrast may be a further
example of differences in renal transcriptional HO-1 reaction
between humans and other species. Marked differences are
known between human and murine renal HO-1 gene
responses to various stimuli, including heat shock, hypoxia,
and hyperosmolarity.35
OA-BSA significantly escalated cellular IL-6 protein mass
beyond the level induced by BSA alone. As IL-6 gene
expression was increased to a similar degree by the two
treatments, these data suggest that the critical effect of
albumin-bound FAs in the promotion of PTEC proinflam-
matory capacity may be at the level of gene translation rather
than transcription. OA-BSA-induced IL-6 was suppressed by
CCCP and ROT, confirming the key role of mitochondria-
derived oxidant stress, as well as by EUK-8, emphasizing the
importance of SOD. FAs may play a crucial role in the
translational control of IL-6 expression, and albumin-bound
lipids could escalate proinflammatory tendencies within
PTECs by driving the gene translation of IL-6 and possibly
other cytokines, via ROS-dependent mechanisms. Such
effects may at least partly explain our16 and others17,18
observations that FA-loaded albumin causes more renal
damage in vivo than albumin alone.
In summary, our findings offer new insights into
mechanisms by which albumin-bound FAs can induce
oxidative stress and oxidant-dependent changes in PTECs.
Bound oleic acid aggravates albumin-induced oxidative stress
via increased mitochondrial ROS production and frustration
of protective SOD2 transcriptional response, indicating a
major pro-oxidant shift in mitochondrial redox balance that
may promote proinflammatory cytokine mechanisms. The
HO-1 response, another important protective mechanism, is
also impaired. These observations support the notion of
albumin as a ‘Trojan horse’, transporting into tubular cells
harmful FAs that depress the cellular defence against ROS.
MATERIALS AND METHODS
Cell culture and model characterization
We utilized HK-2 cells, immortalized epithelial cells derived from
human proximal tubules (obtained from the Department of
Pathology, UMC Utrecht, The Netherlands). Cells were cultured at
371C and 5% CO2, using Gibco Rosewell Park Memorial Institute
1640 medium (with 25 mM N-2-hydroxyethylpiperazine-N0-2-etha-
nesulfonic acid buffer and L-glutamine) (Invitrogen, Breda, The
Netherlands) supplemented with 10% fetal calf serum, sodium
bicarbonate, 100 U/ml penicillin, and 100 mg/ml streptomycin. HK-2
cells are well characterized for proximal tubular epithelial pheno-
type.36,37
SOD 
GPx 
.O2
–
H2O + O2H2O2
.OH
H2O + GSSG
PTEC stimulation 
Ca talase 
EUK -8 
Figure 5 | Schema of ROS pathways of interest. Abbreviations:
KO2
, superoxide anion, H2O2, hydrogen peroxide; GPx, glutathione
peroxidase; GSSG, oxidized glutathione; H2O, water; O2, molecular
oxygen; KOH, hydroxyl ion.
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Albumin uptake
To establish that HK-2 cells are suitable for albumin overload studies
with or without added FAs, we quantified BSA uptake. Cells were
grown to confluence in six-well plates, serum-starved for 24 h,
exposed to 3–30 g/l BSA or OA-BSA for 2 h, and washed. Cells were
homogenized, and the supernatant stored at 201C. Total protein was
measured by the Bradford method. BSA was measured by
immunoelectrophoresis using a rabbit anti-BSA antibody (Nordic
Laboratories, Tilburg, The Netherlands). Results are expressed as BSA
relative to total protein. To visualize intracellular BSA, cells were
grown to confluence on eight-well Lab-Tek chamber slides (Nalge
Nunc, Naperville, IL, USA), treated as above, and stained with a
rabbit anti-BSA antibody (Nordic) and a goat anti-rabbit secondary
antibody (Powervision) (Klinipath, Leiden, The Netherlands).
Cell treatments
Chemicals and reagents were obtained from Sigma Aldrich
(Zwijndrecht, The Netherlands) unless otherwise indicated. We
selected OA as our model FA, being the most abundant FA on
urinary albumin;11 moreover, albumin-bound OA increased ROS in
vascular endothelial cells38 and induced a more pronounced
fibrogenic response in PTECs than other FAs.10 To prepare albumin
solutions, BSA with very low endotoxin content (o1 ng/mg) (Sigma
A-9430) was dissolved in phosphate-buffered saline. For OA-BSA
solutions, OA (Sigma O-1008) was added to fresh BSA solutions,
mixtures incubated for 2.5 h at 371C with gentle shaking, filtered
(0.22mm), aliquoted, and stored at 201C. FA spectra in the
solutions were determined by gas chromatography as described by
Muskiet et al.39 Briefly, 100 ml of BSA or OA-BSA solution mixed
with 1 mg butylated hydroxytoluene (an antioxidant) and 50 mg
margaric acid (17:0, internal quantification standard) was injected
into a gas chromatograph. In samples of solutions that we used for
experiments, BSA contained very low levels (o0.025 mmol/l) of
long-chain FAs like palmitic, linoleic, oleic, stearic, and vaccenic
acids, whereas OA content was very high in OA-BSA,B1.7 mmol/l.
Thus, although during the preparation protocol we added OA to
BSA solutions at a molar ratio of 6/1 OA/BSA, the actual uptake of
OA by BSA corresponded to B3.6/1 OA/BSA, consistent with
findings that albumin has only three high-affinity, primary long-
chain FA binding sites, and other weaker, secondary sites with lower
affinity.40
In the first series of experiments, cells were treated with BSA
(3–30 g/l) alone or complexed with oleic acid (OA-BSA), and ROS
measured for 2 h with the dichlorofluorescein (DCF) assay
(described below). In subsequent experiments, cells were exposed
to an optimal concentration of OA-BSA (at 30 g/l) for 2 h with or
without co-treatment with various agents chosen to answer specific
study questions. Agents employed were APO (1 mM), allopurinol
(ALLO, 100 mM), CCCP (10 mM), 2-thenoyltrifuoroacetone (10 mM),
rotenone (ROT) (10mM), N-o-nitro-L-arginine methyl ester (2 mM)
(ICN Biomedicals, Aurora, OH, USA), and EUK-8 (10 mM)
(Calbiochem, Merck, Nottingham, UK). Concentrations employed
were determined during pilot studies. Stock solutions were diluted
to final working concentrations with phosphate-buffered saline
supplemented with 0.9 mM CaCl2, 0.45 mM MgCl2, and 5 mM glucose
(phosphate-buffered salineþ þ þ ). Control (untreated) cells for
each intervention were incubated with corresponding vehicle
solutions. With agents that generated excessive background signal
during pilot experiments (APO, EUK-8), the protocol was modified
by overnight preincubation and thorough washing before measure-
ments.
ROS measurement
Intracellular ROS were measured with the membrane-permeable
fluorescent probe 20,70-dichlorodihydrofluorescein diacetate
(H2DCFDA) (Invitrogen/Molecular Probes, Merelbeke, Belgium).
Upon deacetylation following cell entry, the molecule is retained
intracellularly. On reaction with ROS, it yields fluorescent DCF. We
detected and quantified DCF fluorescence by microplate fluoro-
spectrometry41 using a FLUOstar Optima reader (BMG Labtechno-
logies, Durham, NC, USA) at excitation and emission wavelengths
of 485 and 520 nm. HK-2 cells were grown to confluence in 96-well
flat-bottom microplates (Corning, NY, USA), serum-starved for
24 h, incubated at 371C with 20 mM H2DCFDA in the dark for
30 min, and washed to remove excess probe. Experimental
treatments were then commenced (371C) and DCF fluorescence
was monitored at 1–2 min intervals during treatment. Fluorescence
slopes were computed per well. Background correction was by assay
of nonspecific fluorescence from identically treated but unlabelled
cells. In validation experiments, HK-2 cells treated with cumene
hydroperoxide (10–500mM) for 30 min showed dose-dependent
increases in DCF signal (data not shown). In general, experiments
were carried out at least in triplicate, and repeated at least twice.
Results are expressed as mean fluorescence slope ratios normalized
to corresponding vehicle control (7s.e.m.).
Cell viability
We used LDH release and MTT tests, by spectrophotometry with
Ultramark microplate system (Bio-Rad Laboratories, Hercules, CA,
USA). (a) LDH assay: To measure released LDH, incubation buffer
was aspirated from each well and transferred to a fresh microplate.
To measure residual cellular LDH, cells were lysed with 0.1% Triton
X-100 in phosphate-buffered saline. Then for both measurements,
50 ml of a pre-heated assay mix (371C) containing 9 mM pyruvate
(Merck, Darmstadt, Germany) and 1.41 mM NADH (ICN, Am-
sterdam, The Netherlands) was added per well and absorbance
quickly read at 340 nm. We computed total LDH, and calculated the
released LDH as a percentage of total. (b) MTT assay: Incubation
buffer was replaced with 0.5 mg/ml MTT (Sigma) and cells further
incubated for 90 min at 371C. MTT was aspirated and the formazan
product released by incubation with acidified (0.04 N HCl)
isopropanol for 15 min with gentle shaking. Absorbance was read
at 570 nm.
Gene expression studies
We assessed gene expression by semiquantitative reverse transcrip-
tion-polymerase chain reaction. Cells were grown to confluence in
six-well plates and rested in serum-free medium for 24 h. After
experimental exposures for 2 h, cells were solubilized in TRIzol
reagent (Invitrogen). Total RNA extraction from TRIzol solution was
performed using the procedure recommended by the manufacturer.
Extracted RNA was dissolved in distilled water, yields determined
with a UV Mini 1240 spectrophotometer (Shimadzu, Duisburg,
Germany), and stored at 801C. Reverse transcription was carried
out in batches of 5 mg total RNA per sample, with 1 mg of random
hexanucleotide added to a total volume of 11 ml. The solution was
heated to 701C for 10 min, and RT performed in 30ml of reaction
volume containing 500 mM deoxynucleoside triphosphate (Ambion
Europe, Huntingdon, UK), 20 U RNAseOUT recombinant ribonu-
clease inhibitor, 1 first-strand buffer, 10 mM dithiothreitol, and
200 U Superscript II reverse transcriptase (Invitrogen) at 421C for
2 h. The volume was heated to 951C for 2 min and then immediately
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cooled on ice. The cDNA samples were stored at 201C. Polymerase
chain reaction conditions were optimized for each gene. Typically,
PCR was performed in 50ml volumes containing cDNA, 10 mM
Tris-HCl (pH 8.3), 50 mM KCl, 200 mM deoxynucleoside tripho-
sphate, 1.5 mM MgCl2, 1.25 U Taq DNA polymerase (Invitrogen),
and 125 ng sense and antisense primers (Sigma-Genosys, Haverhill,
UK) (Table 4). Negative controls contained a PCR mix without
cDNA. PCR was run at 951C (30 s), 551C (30 s), and 721C (30 s) over
30 or 35 cycles, using a PTC-200 DNA Engine (MJ Research,
Watertown, MA, USA). PCR products were run on a 2% agarose gel
containing ethidium bromide (17 ml/l agarose; MP Biomedicals,
Irvine, CA, USA). Gels were photographed with Chemidoc XRS
system (Bio-Rad) and images analyzed with Quantity One software
(Bio-Rad). Negative controls showed no bands. Results are
presented as 18S-corrected intensities relative to control values for
each gene.
IL-6 enzyme-linked immunosorbent assay
A human IL-6 sandwich enzyme-linked immunosorbent assay kit
(Biolegend Inc., San Diego, CA, USA) was used. Cells were grown to
confluence in six-well plates, serum-starved for 24 h, exposed to
30 g/l BSA or OA-BSA for 2 h in the presence or absence of
interventions as specified, and washed. Cells were then homogenized
and the supernatants stored at 201C. For the enzyme-linked
immunosorbent assay procedure, 100 ml capture antibody in coating
buffer was added to each well of a 96-well plate, and incubated
overnight at 41C. After washing and blocking, 100ml of suitably
diluted standards and samples were added to appropriate wells,
incubated at room temperature for 2 h, and thoroughly washed. In
subsequent steps, to each well were added 100ml of diluted
Biotinylated Detection Antibody in Assay Diluent (incubated at
room temperature for 1 h, then washed), 100 ml of diluted Av-
horseradish peroxidase in Assay Diluent (at room temperature for
30 min and washed), 100 ml of 3,30,5,50-tetramethyl benzidine
substrate (in the dark for 15 min), and finally 100 ml of stop
solution, followed by absorbance reading at 450 nm.
Statistics
Data are shown as mean (s.e.m.) unless otherwise indicated.
Differences among groups were analyzed using one-way or two-
way analysis of variance as appropriate; other statistical tests are
indicated where used. Statistical significance was accepted at the
level of Po0.05.
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